Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cachexia × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 11 Stomach Neoplasms 10 Prostatic Neoplasms 10 Neoplasms 10 Endometrial Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Carcinoma, Hepatocellular 5 Sarcoma 4 Recurrence 4 Esophageal Neoplasms 4 Colonic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Gastrointestinal Stromal Tumors 3 Gallbladder Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Venous Thromboembolism 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2 Rectal Neoplasms 2

Interventions

Megestrol Acetate 5 Exercise 4 Standard of Care 3 Blood Specimen Collection 3 dermcidin 2 Resistance Training 2 Physical Therapy Modalities 2 Olanzapine 2 Nutrition Assessment 2 Mirtazapine 2 Ibuprofen 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 bermekimab 1 anamorelin 1 Vitamin D 1 Ultrasonography 1 Retrospective Studies 1 Radiotherapy 1 Powders 1 Omacor 1 Observation 1 Nutritional Status 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03789136 2021-06-29

COMUNEX

Wageningen University

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡